Target intelligence / Profile preview

T cell receptor beta variable 11-3 (TRBV11-3)

Target
TRBV11-3
Molecular classification
Receptor, Immunoglobulin superfamily, Variable domain of T cell receptor beta chain
01

Overview

**T cell receptor beta variable 11-3** (TRBV11-3) is a variable region segment of the T cell receptor (TCR) beta chain that forms part of the antigen recognition interface of αβ T cells. The TCR is a membrane-bound heterodimeric protein complex present on the surface of most T lymphocytes and is essential for the adaptive immune system's ability to recognize processed antigen fragments presented by major histocompatibility complex (MHC) molecules. The TRBV11-3 gene segment specifically encodes the variable region of the beta chain, contributing to the diversity and specificity of antigen recognition. T cells expressing TCRs utilizing TRBV11-3 are involved in both normal immune surveillance and pathologic clonal expansions in diseases such as leukemia. The TCR complex, including TRBV11-3-containing receptors, propagates intracellular signaling required for T cell activation, proliferation, and effector functions upon engagement with an MHC-peptide complex[1][2][3][4][5].

Other names
T cell receptor beta variable 11-3TRBV11-3TCRBV21S2A2TRBV113TCRBV11S3V segment translation product
02

Mechanism of action

Drugs or therapeutics targeting T cell receptor (TCR) complexes generally function by modulating TCR signaling, blocking antigen recognition, or depleting T cells by targeting TCR or its associated proteins[3].

03

Biological functions

Antigen recognitionSignal transductionImmune response
04

Disease associations

Cancer (notably T cell acute lymphoblastic leukemia and other immune-related neoplasms)InflammationInfection
05

Safety considerations

Immunosuppression and cytokine release syndrome are general concerns for therapies targeting TCR or T cells. Off-target immune modulation may occur with broad-acting TCR-targeted agents[3].
06

Biomarkers

Clonotypic TCR sequences (including TRBV11-3 variants) can be used as biomarkers in leukemia and other disorders involving T cell clonality[3].

Beyond the preview

Go deeper on T cell receptor beta variable 11-3 (TRBV11-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 11-3 (TRBV11-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call